Literature DB >> 33644129

Ivabradine and Blood Pressure Reduction: Underlying Pleiotropic Mechanisms and Clinical Implications.

Fedor Simko1,2,3, Tomas Baka1.   

Abstract

Entities:  

Keywords:  blood pressure; endothelial dysfunction; ivabradine; neurohumoral activation; vascular stiffness

Year:  2021        PMID： 33644129      PMCID： PMC7902523          DOI： 10.3389/fcvm.2021.607998

Source DB:  PubMed          Journal:  Front Cardiovasc Med        ISSN： 2297-055X


× No keyword cloud information.
  74 in total

1.  Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients.

Authors:  Ivano Bonadei; Edoardo Sciatti; Enrico Vizzardi; Davide Fabbricatore; Mattia Pagnoni; Laura Rossi; Valentina Carubelli; Carlo M Lombardi; Marco Metra
Journal:  Cardiovasc Ther       Date:  2018-03-06       Impact factor: 3.023

2.  Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension.

Authors:  Paolo Palatini; Enrico Agabiti Rosei; Edoardo Casiglia; John Chalmers; Roberto Ferrari; Guido Grassi; Teruo Inoue; Bojan Jelakovic; Magnus T Jensen; Stevo Julius; Sverre E Kjeldsen; Giuseppe Mancia; Gianfranco Parati; Paolo Pauletto; Andrea Stella; Alberto Zanchetti
Journal:  J Hypertens       Date:  2016-05       Impact factor: 4.844

3.  Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress.

Authors:  Swenja Kröller-Schön; Eberhard Schulz; Philip Wenzel; Andrei L Kleschyov; Marcus Hortmann; Michael Torzewski; Matthias Oelze; Thomas Renné; Andreas Daiber; Thomas Münzel
Journal:  Basic Res Cardiol       Date:  2011-10-02       Impact factor: 17.165

4.  Nocturnal nondipping of heart rate predicts cardiovascular events in hypertensive patients.

Authors:  Kazuo Eguchi; Satoshi Hoshide; Joji Ishikawa; Thomas G Pickering; Joseph E Schwartz; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Hypertens       Date:  2009-11       Impact factor: 4.844

5.  Blunted heart rate dip during sleep and all-cause mortality.

Authors:  Iddo Z Ben-Dov; Jeremy D Kark; Drori Ben-Ishay; Judith Mekler; Liora Ben-Arie; Michael Bursztyn
Journal:  Arch Intern Med       Date:  2007-10-22

Review 6.  Ivabradine for the Treatment of Cardiovascular Diseases.

Authors:  Tomomi Ide; Kisho Ohtani; Taiki Higo; Makoto Tanaka; Yasushi Kawasaki; Hiroyuki Tsutsui
Journal:  Circ J       Date:  2018-12-29       Impact factor: 2.993

7.  Ivabradine in stable coronary artery disease without clinical heart failure.

Authors:  Kim Fox; Ian Ford; Philippe Gabriel Steg; Jean-Claude Tardif; Michal Tendera; Roberto Ferrari
Journal:  N Engl J Med       Date:  2014-08-31       Impact factor: 91.245

8.  Effect of chronic heart rate reduction with ivabradine on carotid and aortic structure and function in normotensive and hypertensive rats.

Authors:  P Albaladejo; A Carusi; A Apartian; P Lacolley; M E Safar; A Bénétos
Journal:  J Vasc Res       Date:  2003-07-29       Impact factor: 1.934

9.  Ivabradine reduces chemokine-induced CD4-positive lymphocyte migration.

Authors:  Thomas Walcher; Peter Bernhardt; Dusica Vasic; Helga Bach; Renate Durst; Wolfgang Rottbauer; Daniel Walcher
Journal:  Mediators Inflamm       Date:  2010-12-05       Impact factor: 4.711

10.  Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension.

Authors:  Fedor Simko; Tomas Baka; Marko Poglitsch; Kristina Repova; Silvia Aziriova; Kristina Krajcirovicova; Stefan Zorad; Michaela Adamcova; Ludovit Paulis
Journal:  Int J Mol Sci       Date:  2018-10-03       Impact factor: 5.923
View more
  4 in total

1.  Ivabradine Ameliorates Cardiac Function in Heart Failure with Preserved and Reduced Ejection Fraction via Upregulation of miR-133a.

Authors:  Shuai Shao; Yue Zhang; Mengqi Gong; Qian Yang; Meng Yuan; Ming Yuan; Ya Suo; Xinghua Wang; Ying Li; Qiankun Bao; Guangping Li
Journal:  Oxid Med Cell Longev       Date:  2021-09-29       Impact factor: 6.543

Review 2.  Cardiovascular therapeutics: A new potential for anxiety treatment?

Authors:  Kristina Repova; Silvia Aziriova; Kristina Krajcirovicova; Fedor Simko
Journal:  Med Res Rev       Date:  2022-01-06       Impact factor: 12.388

3.  Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin-Angiotensin-Aldosterone System.

Authors:  Fedor Simko; Tomas Baka; Peter Stanko; Kristina Repova; Kristina Krajcirovicova; Silvia Aziriova; Oliver Domenig; Stefan Zorad; Michaela Adamcova; Ludovit Paulis
Journal:  Biomedicines       Date:  2022-07-31

4.  Adaptation of Arterial Wall Viscosity to the Short-Term Reduction of Heart Rate: Impact of Aging.

Authors:  Frédéric Roca; Michèle Iacob; Thomas Duflot; Nathalie Donnadieu; Caroline Thill; Jérémy Bellien; Robinson Joannides
Journal:  J Am Heart Assoc       Date:  2022-02-03       Impact factor: 6.106
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.